...The companies partnered to produce antibody fragments for ImaginAb using Eurogentec's Pichia pastoris expression system. ImaginAb... ...agents for the diagnosis and treatment of cancer and autoimmune diseases. Further terms not disclosed. Eurogentec S.A....
...Supply/Service company Eurogentec will acquire proteomics company AnaSpec for an undisclosed sum. AnaSpec's marketed products include... ...assays, SensoLyte assays for high throughput screening and drug discovery, and dye-labeled peptides for diagnostics. Eurogentec... ...includes Eurogentec's OliGold custom oligonucleotides. Achelous Partners LLC advised AnaSpec. AnaSpec Inc. , Fremont, Calif. Eurogentec S.A....
...CYGX and Eurogentec signed a letter of intent to develop undisclosed products using CYGX's synDNA production... ...influenza, HIV/AIDS, smallpox and HBV. Further terms were not disclosed. CytoGenix Inc. (CYGX), Houston, Texas Eurogentec S.A....
...granted E2 million ($2.6 million) to the Vasoplus research consortium, which consists of THR, Geymonat, Eurogentec... ...is a homolog of vascular endothelial growth factor (VEGF) and is currently in preclinical testing. Eurogentec S.A....
...Oxford granted Eurogentec a license to Southern array patents, which cover the manufacture, use and marketing... ...which cover the manufacture, use and marketing of oligonucleotide microarrays. Further terms were not disclosed. Eurogentec S.A....
...ALNY granted Eurogentec a non-exclusive license to its RNAi patents, for use in developing research products... ...and their use to mediate RNAi in mammalian cells. Alnylam Pharmaceuticals Inc. (ALNY), Cambridge, Mass. Eurogentec S.A....
...on its MGB Eclipse Probe System business. Also, the companies expanded a 2002 deal for Eurogentec... ...and Japan. As expanded, the deal includes North America. Epoch Biosciences Inc. (EBIO), Bothell, Wash Eurogentec S.A....
...The companies partnered to produce antibody fragments for ImaginAb using Eurogentec's Pichia pastoris expression system. ImaginAb... ...agents for the diagnosis and treatment of cancer and autoimmune diseases. Further terms not disclosed. Eurogentec S.A....
...Supply/Service company Eurogentec will acquire proteomics company AnaSpec for an undisclosed sum. AnaSpec's marketed products include... ...assays, SensoLyte assays for high throughput screening and drug discovery, and dye-labeled peptides for diagnostics. Eurogentec... ...includes Eurogentec's OliGold custom oligonucleotides. Achelous Partners LLC advised AnaSpec. AnaSpec Inc. , Fremont, Calif. Eurogentec S.A....
...CYGX and Eurogentec signed a letter of intent to develop undisclosed products using CYGX's synDNA production... ...influenza, HIV/AIDS, smallpox and HBV. Further terms were not disclosed. CytoGenix Inc. (CYGX), Houston, Texas Eurogentec S.A....
...granted E2 million ($2.6 million) to the Vasoplus research consortium, which consists of THR, Geymonat, Eurogentec... ...is a homolog of vascular endothelial growth factor (VEGF) and is currently in preclinical testing. Eurogentec S.A....
...Oxford granted Eurogentec a license to Southern array patents, which cover the manufacture, use and marketing... ...which cover the manufacture, use and marketing of oligonucleotide microarrays. Further terms were not disclosed. Eurogentec S.A....
...ALNY granted Eurogentec a non-exclusive license to its RNAi patents, for use in developing research products... ...and their use to mediate RNAi in mammalian cells. Alnylam Pharmaceuticals Inc. (ALNY), Cambridge, Mass. Eurogentec S.A....
...on its MGB Eclipse Probe System business. Also, the companies expanded a 2002 deal for Eurogentec... ...and Japan. As expanded, the deal includes North America. Epoch Biosciences Inc. (EBIO), Bothell, Wash Eurogentec S.A....